Do you have trouble sleeping in the morning or in the middle of the night? This can affect your risk of developing dementia.

Published Date: 08 Mar 2023

Along with growing evidence of poor sleep and cognitive impairment, a new study has found an association between three measures of sleep and the risk of developing dementia by age 10. ...

Read Full News

Latest News

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

What Is Causing This Case of Sudden Aphasia?

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Neuropathy After Recreational Use of Laughing Gas

Clinicians should be aware of adverse effects of this increasingly popular drug

Vitamin C and the Brain; Invisible MS Lesions Revealed; Profound Autism Definition

News and commentary from the world of neurology and neuroscience

Alzheimer's Biomarkers Change After Tuberculosis Vaccination

BCG vaccine altered immune responses and modified amyloid-beta, study shows

Modified Amino Acid Improves Neurologic Symptoms in Rare Genetic Disorder

— Levacetylleucine succeeds in phase III trial of adults and kids with ataxia-telangiectasia

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Clinicians should be aware of adverse effects of this increasingly popular drug

News and commentary from the world of neurology and neuroscience

BCG vaccine altered immune responses and modified amyloid-beta, study shows

— Levacetylleucine succeeds in phase III trial of adults and kids with ataxia-telangiectasia

News All Time

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Brain Worm Lesions Mimicking Cancer; Midlife Dementia Marker; Ovarian Reserve and MS

News and commentary from the world of neurology and neuroscience

Trump Actions Signal Move Toward Institutionalizing Disabled People, Advocates Warn

The Education Department announced it would offload oversight of special education to HHS

Persistent Double Vision Follows Insidious Onset of Ptosis in Healthy Man

High-resolution MRI aids in differential diagnosis

Man Goes Blind After Binging on Booze and Crystal Meth

Look beyond uremia and acidosis for rare cause of lentiform fork sign on MRI, authors say

Emails Reveal How RFK Jr. Empowered a Lone CDC Scientist

William Thompson made demands of and criticized CDC leadership

Off-Label Drug Proves Its Mettle in Relapsing Multiple Sclerosis

Rituximab and ocrelizumab go head to head in randomized trial

Why Danny Glover Is Speaking Publicly About His Alzheimer's Disease

By sharing his experience, the actor is helping others understand they are not alone

Recommended News For You

Combination therapy improves outcomes for advanced triple-negative breast cancer

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

Stem Cell Selection Unneeded for SSc Transplant Therapy?

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Ranking of the Best US Hospitals for Psychiatric Care.

Why are so many young adults getting cancer?

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Healthy Hematopoietic Aging and Disease Avoidance: Mechanisms, Clinical Insights, and Future Directions 

Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking Charge of Your Cancer Journey.

2.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

5.

"We Caught It Early": Advantage or Disadvantage?

1.

How HLH is Revolutionizing Healthcare

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot